Greetings from another new member M61 ET CALR+
Posted: Tue Jan 02, 2024 11:38 am
Greetings all.
I'm a male (Peter) aged 61 living near Sydney NSW and spend approximately 6 months each year in Sweden (access to the Swedish health system is difficult for me. That's a long story.).
A regular blood test with my GP back in 2012 (aged 50) showed slightly elevated platelets and I was referred to A/Prof Ilona Cunningham at Concord Hospital.
I was diagnosed with ET and later CALR+. I don't know if I'm Type 1 or Type 2 because it was the early days of that test.
After my platelets exceeded 1000 I was put on Hydroxyurea, starting at 1 tablet and now, about 11 years later, I am on 4 tablets daily.
I have no obvious symptoms from ET nor side affects from HU. Later I was transferred from Dr Cunningham to Dr Nicole Wong Doo.
So far so good. But lately the 4 tablets is also knocking my white and red blood cells too low and Dr Wong Doo mentioned I may need to transition to Pegasys. I know there are a lot of fans of Pegasys but it threw me into a spin (and my first ET related anxiety). I travel to a lot to interesting places often for 6 months at a time and the thought of travelling with sharps, drugs, cooling equipment, airport security, hotel fridges of varying effectiveness, tropical heat, the quantity of drugs needed for 6 months and the associated customs paperwork and the cost of replacing drugs should they spoil was complexity I really don't want to manage.
I'm now seeking alternative views on switching to Pegasys and I'm slowly getting my ahead around the idea. I'm super excited about the soon-to-run trials of the CALR antibodies and will discuss with my specialist when to jump on board - I suspect the right answer is not yet. Is it sensible to stay on HU until Phase 2 of one of the trials???
Anyway - this latest development in my story has lead me to read lots of medical papers (including learning a whole new jargon) and other information sources (such as MPN Mates) to better understand my conditions and the implications of medication options.
I'm pleased to be here and look forward to contributing to the community.
I'm a male (Peter) aged 61 living near Sydney NSW and spend approximately 6 months each year in Sweden (access to the Swedish health system is difficult for me. That's a long story.).
A regular blood test with my GP back in 2012 (aged 50) showed slightly elevated platelets and I was referred to A/Prof Ilona Cunningham at Concord Hospital.
I was diagnosed with ET and later CALR+. I don't know if I'm Type 1 or Type 2 because it was the early days of that test.
After my platelets exceeded 1000 I was put on Hydroxyurea, starting at 1 tablet and now, about 11 years later, I am on 4 tablets daily.
I have no obvious symptoms from ET nor side affects from HU. Later I was transferred from Dr Cunningham to Dr Nicole Wong Doo.
So far so good. But lately the 4 tablets is also knocking my white and red blood cells too low and Dr Wong Doo mentioned I may need to transition to Pegasys. I know there are a lot of fans of Pegasys but it threw me into a spin (and my first ET related anxiety). I travel to a lot to interesting places often for 6 months at a time and the thought of travelling with sharps, drugs, cooling equipment, airport security, hotel fridges of varying effectiveness, tropical heat, the quantity of drugs needed for 6 months and the associated customs paperwork and the cost of replacing drugs should they spoil was complexity I really don't want to manage.
I'm now seeking alternative views on switching to Pegasys and I'm slowly getting my ahead around the idea. I'm super excited about the soon-to-run trials of the CALR antibodies and will discuss with my specialist when to jump on board - I suspect the right answer is not yet. Is it sensible to stay on HU until Phase 2 of one of the trials???
Anyway - this latest development in my story has lead me to read lots of medical papers (including learning a whole new jargon) and other information sources (such as MPN Mates) to better understand my conditions and the implications of medication options.
I'm pleased to be here and look forward to contributing to the community.